Literature DB >> 9703471

1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase.

P J Perry1, S M Gowan, A P Reszka, P Polucci, T C Jenkins, L R Kelland, S Neidle.   

Abstract

A number of 1,4- and 2,6-difunctionalized amidoanthracene-9, 10-diones have been prepared. We have examined their in vitro cytotoxicity in several tumor cell lines and their ability to inhibit the telomere-addition function of the human telomerase enzyme together with their inhibition of the Taq polymerase enzyme. Compounds with -(CH2)2- side chains terminating in basic groups such as piperidine show inhibition of telomerase at telIC50 levels of 4-11 microM. These are thus among the most potent nonnucleoside telomerase inhibitors reported to date. Cytotoxicity levels in human tumor cell lines were at comparable levels for several compounds. Implications for amidoanthracene-9,10-dione telomerase inhibitors as potential anticancer agents are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9703471     DOI: 10.1021/jm9801105

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  16 in total

Review 1.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

2.  Stabilisation of TG- and AG-containing antiparallel DNA triplexes by triplex-binding ligands.

Authors:  M D Keppler; S Neidle; K R Fox
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

3.  Platinum cross-linking of adenines and guanines on the quadruplex structures of the AG3(T2AG3)3 and (T2AG3)4 human telomere sequences in Na+ and K+ solutions.

Authors:  Sophie Redon; Sophie Bombard; Miguel-Angel Elizondo-Riojas; Jean-Claude Chottard
Journal:  Nucleic Acids Res       Date:  2003-03-15       Impact factor: 16.971

Review 4.  DNA G-quadruplexes, telomere-specific proteins and telomere-associated enzymes as potential targets for new anticancer drugs.

Authors:  E Raymond; J C Soria; E Izbicka; F Boussin; L Hurley; D D Von Hoff
Journal:  Invest New Drugs       Date:  2000-05       Impact factor: 3.850

5.  Mechanism of telomerase activation by v-Rel and its contribution to transformation.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Andrew S Liss; Henry R Bose
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  The interaction of telomeric DNA and C-myc22 G-quadruplex with 11 natural alkaloids.

Authors:  Xiaohui Ji; Hongxia Sun; Huaxi Zhou; Junfeng Xiang; Yalin Tang; Changqi Zhao
Journal:  Nucleic Acid Ther       Date:  2012-04       Impact factor: 5.486

7.  Inhibition of telomerase by linear-chain fatty acids: a structural analysis.

Authors:  Masako Oda; Takamasa Ueno; Nobuyuki Kasai; Hirotada Takahashi; Hiromi Yoshida; Fumio Sugawara; Kengo Sakaguchi; Hideya Hayashi; Yoshiyuki Mizushina
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 8.  G-quadruplex virtual drug screening: A review.

Authors:  Robert C Monsen; John O Trent
Journal:  Biochimie       Date:  2018-06-30       Impact factor: 4.079

Review 9.  Applications of isothermal titration calorimetry in biophysical studies of G-quadruplexes.

Authors:  Bruno Pagano; Carlo Andrea Mattia; Concetta Giancola
Journal:  Int J Mol Sci       Date:  2009-07-02       Impact factor: 6.208

10.  New approaches of PARP-1 inhibitors in human lung cancer cells and cancer stem-like cells by some selected anthraquinone-derived small molecules.

Authors:  Yu-Ru Lee; Dah-Shyong Yu; Ya-Chun Liang; Kuo-Feng Huang; Shih-Jie Chou; Tsung-Chih Chen; Chia-Chung Lee; Chun-Liang Chen; Shih-Hwa Chiou; Hsu-Shan Huang
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.